Nu Skin Enterprises (NYSE:NUS) Issues Quarterly Earnings Results

Nu Skin Enterprises (NYSE:NUS) issued its quarterly earnings results on Friday. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01), FiscalAI reports. The firm had revenue of $320.61 million for the quarter, compared to analysts’ expectations of $329.70 million. Nu Skin Enterprises had a net margin of 3.78% and a return on equity of 7.46%.

Nu Skin Enterprises Price Performance

Shares of Nu Skin Enterprises stock traded up $0.11 on Friday, hitting $7.13. 784,395 shares of the company traded hands, compared to its average volume of 432,990. Nu Skin Enterprises has a 52 week low of $6.34 and a 52 week high of $14.62. The business has a 50-day simple moving average of $7.48 and a 200 day simple moving average of $9.21. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.40 and a current ratio of 2.08. The stock has a market capitalization of $343.31 million, a P/E ratio of 6.48 and a beta of 1.03.

Nu Skin Enterprises Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 10th. Stockholders of record on Friday, May 29th will be given a dividend of $0.06 per share. The ex-dividend date is Friday, May 29th. This represents a $0.24 annualized dividend and a dividend yield of 3.4%. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently 7.50%.

More Nu Skin Enterprises News

Here are the key news stories impacting Nu Skin Enterprises this week:

• Positive Sentiment: Nu Skin declared a quarterly cash dividend of $0.06 per share, signaling continued capital returns to shareholders and supporting the stock’s income appeal.
• Neutral Sentiment: Coverage updates and the earnings call transcript from Stonegate Capital and Seeking Alpha mainly repeat the quarter’s reported figures and do not add a new catalyst.
• Negative Sentiment: Q1 2026 EPS of $0.14 missed estimates of $0.15, and revenue of $320.6 million fell short of the $329.7 million consensus, reinforcing concerns about softer demand. Article Title
• Negative Sentiment: The company also lowered Q2 2026 and FY 2026 outlooks versus analyst expectations, which likely weighed on sentiment because it suggests limited near-term growth visibility.
• Negative Sentiment: Operating trends remained weak, with year-over-year declines in customers, paid affiliates, and sales leaders, pointing to ongoing pressure in the core business.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on NUS shares. Weiss Ratings restated a “hold (c)” rating on shares of Nu Skin Enterprises in a research note on Thursday, January 22nd. Wall Street Zen lowered Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Saturday, February 14th. Finally, Zacks Research raised Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a report on Monday, April 13th. Two investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Nu Skin Enterprises currently has a consensus rating of “Hold”.

Hedge Funds Weigh In On Nu Skin Enterprises

Institutional investors have recently bought and sold shares of the stock. Amundi lifted its stake in Nu Skin Enterprises by 18.8% in the 1st quarter. Amundi now owns 18,564 shares of the company’s stock worth $127,000 after purchasing an additional 2,941 shares in the last quarter. AQR Capital Management LLC grew its position in shares of Nu Skin Enterprises by 64.6% during the first quarter. AQR Capital Management LLC now owns 350,357 shares of the company’s stock valued at $2,530,000 after purchasing an additional 137,475 shares in the last quarter. Dynamic Technology Lab Private Ltd purchased a new position in shares of Nu Skin Enterprises during the first quarter valued at about $162,000. Goldman Sachs Group Inc. increased its holdings in shares of Nu Skin Enterprises by 7.2% in the first quarter. Goldman Sachs Group Inc. now owns 1,319,885 shares of the company’s stock worth $9,582,000 after purchasing an additional 88,088 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its holdings in shares of Nu Skin Enterprises by 9.3% in the second quarter. JPMorgan Chase & Co. now owns 764,052 shares of the company’s stock worth $6,105,000 after purchasing an additional 65,060 shares during the last quarter. 82.84% of the stock is owned by hedge funds and other institutional investors.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.

Founded in 1984 by Blake M.